Physician

Quyen Ngoc Luu, MD

According to 2025 Medicare claims, Quyen Luu, MD (NPI: 1558347427) practices infectious disease in the Macon-Bibb County, GA market, with the plurality of this provider's patient population coming from Bibb, GA. This provider's primary affiliated billing organization is CENTRAL GEORGIA INFECTIOUS DISEASES ASSOCIATES, LLC (NPI: 1932283868; TIN: 20-1072147) and primary practice location at 31201-4200. Luu is affiliated with the TC2, LLC (ACO ID: A3365), participating under the MSSP model.

Luu's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 372 traditional Medicare patients, billed 86,628 HCPCS/CPT codes, and received $1,141,262 in Medicare payments. The top billing code was 11042 (Removal of skin and tissue, 20.0 sq cm or less). Part D data shows 1,049 prescription claims across 212 beneficiaries totaling $1,274,827 in drug costs, led by Biktarvy (Bictegrav/Emtricit/Tenofov Ala). DME data shows 392 claims. Open Payments data shows 64 records totaling $111,072. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $1,252,610 and ending at $1,141,262. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and declined steadily, from $156,934 to $50,842.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	896	53,726	$1,252,610
2016	676	50,559	$1,032,548
2017	675	82,347	$1,357,069
2018	821	82,396	$1,808,857
2019	842	143,432	$2,051,798
2020	809	89,650	$1,449,338
2021	621	57,982	$2,004,266
2022	512	47,280	$1,360,289
2023	410	45,605	$1,502,925
2024	372	86,628	$1,141,262

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	297	1,799	$1,769,379
2016	333	1,919	$1,814,099
2017	278	1,542	$1,498,893
2018	284	1,452	$2,216,467
2019	338	1,532	$2,382,975
2020	250	1,089	$1,942,325
2021	230	964	$1,098,271
2022	204	955	$1,229,675
2023	182	816	$1,393,901
2024	212	1,049	$1,274,827

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	422	1,001	$211,675
2016	344	798	$200,070
2017	224	544	$132,651
2018	309	593	$116,825
2019	203	470	$91,956
2020	167	402	$137,154
2021	159	414	$142,713
2022	254	480	$134,791
2023	268	394	$79,299
2024	225	392	$73,612

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
11042	Removal of skin and tissue, 20.0 sq cm or less	135	1,070	$78
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	220	763	$63
80053	Blood test, comprehensive group of blood chemicals	240	548	$10
36415	Insertion of needle into vein for collection of blood sample	254	593	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	232	514	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	80	3,120	$409,767
Gammagard Liquid	Immun Glob G(Igg)/Gly/Iga Ov50	17	357	$181,296
Privigen	Immun Glob G(Igg)/Pro/Iga 0-50	11	308	$102,827
Gamunex-C	Immune Globul G/Gly/Iga Avg 46	32	672	$83,072
Daptomycin	Daptomycin	139	1,024	$74,619

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	N	N/R	13	$32,714
A6010	Collagen based wound filler, dry form, sterile, per gram of collagen	N	40	51	$27,676
Q2052	Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)	N	N/R	11	$3,626
L4361	Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated, off-the-shelf	N	12	13	$3,553
A6011	Collagen based wound filler, gel/paste, per gram of collagen	N	30	39	$2,788

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	42	$1,357	Kerecis Limited
Research Payments	Reported research-related payment or transfer-of-value amount.	22	$109,715	Takeda Pharmaceuticals U.S.A., Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Quyen Ngoc Luu, MD?

Tedicare shows public-source Medicare data for Quyen Ngoc Luu, MD (NPI 1558347427), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Quyen Ngoc Luu, MD have ACO affiliation data?

Quyen Ngoc Luu, MD is shown with ACO affiliation data for TC2, LLC (MSSP, ACO ID A3365).

What billing organization is linked to Quyen Ngoc Luu, MD?

Quyen Ngoc Luu, MD is linked to CENTRAL GEORGIA INFECTIOUS DISEASES ASSOCIATES, LLC (billing NPI 1932283868) in the available physician profile data.

Does Quyen Ngoc Luu, MD have Open Payments data?

Quyen Ngoc Luu, MD has 64 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.